Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 99.
15. lappuse
... packaged , with or without other drugs , solvents , and propellants , in a form suitable for self - medication by external application to the skin as a spray , and containing no drug limited to prescrip- tion sale under the provisions ...
... packaged , with or without other drugs , solvents , and propellants , in a form suitable for self - medication by external application to the skin as a spray , and containing no drug limited to prescrip- tion sale under the provisions ...
16. lappuse
... packaged in a hermetic con- tainer suitable for use in self - medica- tion by external application to the skin , and containing no drug limited to prescription sale under the provisions of section 503 ( b ) ( 1 ) of the act . ( ii ) The ...
... packaged in a hermetic con- tainer suitable for use in self - medica- tion by external application to the skin , and containing no drug limited to prescription sale under the provisions of section 503 ( b ) ( 1 ) of the act . ( ii ) The ...
20. lappuse
... packaged as to volume and type of container as to afford adequate protection and be suit- able for self - medication with a mini- mum risk of contamination of the solu- tion during use . Any dispensing unit is sterile and so packaged as ...
... packaged as to volume and type of container as to afford adequate protection and be suit- able for self - medication with a mini- mum risk of contamination of the solu- tion during use . Any dispensing unit is sterile and so packaged as ...
37. lappuse
... packaged in a plastic immediate con- tainer is not generally recognized as safe and effective , is a new drug within the meaning of section 201 ( p ) of the act , and requires an approved new drug application as a condition for market ...
... packaged in a plastic immediate con- tainer is not generally recognized as safe and effective , is a new drug within the meaning of section 201 ( p ) of the act , and requires an approved new drug application as a condition for market ...
41. lappuse
... packaged in unit- dose packaging . “ Unit - dose packaging " means a method of packaging a prod- uct into a nonreusable container de- signed to hold a single dosage unit in- tended for administration directly from that container ...
... packaged in unit- dose packaging . “ Unit - dose packaging " means a method of packaging a prod- uct into a nonreusable container de- signed to hold a single dosage unit in- tended for administration directly from that container ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning